ABBV-8E12 is an anti-tau antibody being investigated to treat Alzheimer's disease and Progressive Supranuclear Palsy (PSP).

Type of Molecule

Biologic

Target

Tau

Region

n/a

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Progressive Supranuclear Palsy New Indication Phase 2
Alzheimer's Disease (AD) New Indication Phase 2